Welder Health Surveillance: Australia’s Requirements and Best Practice

The occupational history should be detailed and specific; generic questions yield little useful information. Examples of effective questioning: “In the last 12 months, how many hours per week have you spent MIG welding? Have you performed any stainless steel welding? Have you noticed any new respiratory symptoms or changes compared to last year?” This level of detail allows the occupational physician to assess exposure history and contextualize health findings.

Spirometry: Lung Function Measurement

Spirometry measures lung function by having the worker take a deep breath and exhale forcefully into a spirometer, measuring: (1) FVC (forced vital capacity): Total volume of air exhaled, indicative of lung size and elastic recoil. (2) FEV₁ (forced expiratory volume in 1 second): Volume of air exhaled in the first second, indicative of large airway function. (3) FEV₁/FVC ratio: The ratio of FEV₁ to FVC, used to detect airflow obstruction (ratio <0.7 or 0.75 depending on reference values) which is characteristic of chronic obstructive pulmonary disease (COPD) or occupational asthma.

Baseline spirometry is essential at pre-placement; serial spirometry at periodic surveillance (annually or biennially) allows detection of lung function decline. A decline in FEV₁ of >100 mL/year, or >10% decline from baseline over 5 years, may indicate accelerated lung disease possibly related to welding fume exposure. An FEV₁/FVC ratio <0.7 suggests airflow obstruction potentially from occupational asthma or COPD.

Spirometry quality is critical. The test must be performed by trained personnel using calibrated equipment, with proper technique by the worker (maximum effort exhalation). Poor technique yields invalid results. Occupational health services contracted to perform welder surveillance should ensure spirometry is conducted by experienced respiratory technicians.

{{IMAGE_BODY_1}}

Physical Examination with Neurological Focus

Periodic physical examination should include general assessment (vital signs, general health status) and specific focus on systems at risk from welding fume exposure: (1) respiratory examination: Lung auscultation (listening for abnormal sounds), assessment of breathing comfort, and smoking/respiratory symptom history; (2) neurological examination: Gait assessment (walking for signs of gait disturbance or ataxia, which can indicate manganism or other neurotoxic effects), tremor assessment (fine tremor at rest or intentional tremor during movement can indicate manganese accumulation), cognitive assessment (simple tests of orientation and memory), and mood/psychiatric assessment (manganism can present with mood changes, aggression, or cognitive decline).

Neurological examination is critical but is often inadequately performed in standard occupational health assessments. The occupational physician or nurse should receive training in occupational neurotoxicology and manganism-specific signs. A generic medical examination without specific neurological focus may miss early manganism or other neurotoxic effects.

Questionnaire-Based Symptom Surveillance

Standardized questionnaires can systematically capture respiratory and neurological symptoms. Examples include: the British Medical Research Council (BMRC) respiratory questionnaire (assesses cough, phlegm, dyspnea), the ECRHS (European Community Respiratory Health Survey) questionnaire, or the MoCA (Montreal Cognitive Assessment) for cognitive screening. These questionnaires provide consistency and allow longitudinal tracking of symptom development or progression. They also ensure that no symptoms are overlooked because all common symptoms are covered systematically.

Chest X-Ray (When Indicated)

Chest X-ray is not required routinely for all welders but is indicated if: (1) spirometry shows significant lung function decline or obstruction, (2) respiratory symptoms or physical examination findings suggest lung disease, (3) baseline chest X-ray shows abnormality requiring follow-up, or (4) the worker has prolonged exposure to high-fume processes and surveillance aims to detect early pneumoconiosis or other parenchymal lung disease. Pneumoconiosis (lung scarring from chronic inhalation of mineral dusts) can develop from welding fume exposure, though it is less common than COPD. Chest X-ray can identify early interstitial changes (fine shadowing in lung fields) indicative of pneumoconiosis.

Biological Monitoring: Blood Manganese and Chromium Levels

For workers with high exposure to manganese-rich processes (flux-cored arc welding, high-tensile stick welding, stainless steel electrode welding), blood manganese level can supplement air monitoring and physical examination. Normal (non-occupationally exposed) blood manganese is 3–12 μg/L. Occupationally exposed welders typically have levels 10–50 μg/L; levels exceeding 50 μg/L warrant concern. Some occupational hygienists use action levels of 30 μg/L, above which closer exposure assessment or enhanced controls are recommended. However, blood manganese level does not predict neurological outcome; workers with elevated blood manganese may not develop manganism, while workers with apparently normal blood manganese may have high brain manganese accumulation (manganese accumulates preferentially in the brain). Biological monitoring should be integrated with air monitoring and neurological examination rather than relied upon as a single indicator.

Blood chromium level (for stainless steel welders) is less well-standardized. Occupational chromium levels vary widely (0.5–5 μg/L in exposed workers); normal ranges are poorly defined. Urine chromium is sometimes measured as an alternative. Biological monitoring for chromium is less established than for manganese and should not be used as the sole basis for exposure control decisions; air monitoring for Cr(VI) is more reliable.

Health Surveillance Frequency and Scheduling

Baseline (Pre-Placement) Assessment

Before assignment to welding work, each worker should receive: (1) occupational and medical history, (2) baseline spirometry, (3) physical examination, and (4) chest X-ray (if indicated based on history or company policy). This establishes baseline health status for comparison with future surveillance. Baseline assessment should be completed before work begins, not 6 months into employment.

Annual Surveillance for High-Risk Exposures

For workers with high exposure (air monitoring shows concentration >50% of WES, or worker is in high-fume process like FCAW stainless steel), annual surveillance including spirometry, questionnaire, and physical examination is recommended. Annual frequency allows detection of rapid health changes and enables early intervention if disease is developing.

Biennial Surveillance for Moderate-Risk Exposures

For workers with moderate exposure (air monitoring shows 20–50% of WES), biennial (every 2 years) surveillance is acceptable. Two-year intervals allow trend analysis while avoiding excessive testing burden.

Exit Surveillance After Cessation of Exposure

When a welder leaves the organization or moves to non-welding duties, exit surveillance should be conducted including spirometry, questionnaire, and physical examination. Exit assessment documents final health status and provides a reference point if the worker later develops occupational disease and pursues workers’ compensation claims. Exit assessment also identifies any acute health findings requiring medical follow-up or worker notification.

{{IMAGE_BODY_2}}

Interpretation of Surveillance Results and Health Findings

Lung Function Decline: Diagnostic Criteria

Lung function decline is assessed by comparing current FEV₁ (or other spirometry parameters) to baseline. A decline of >10% from baseline, or >100 mL/year decline over the surveillance period, may indicate accelerated respiratory disease. An FEV₁/FVC ratio <0.70 indicates airflow obstruction. Any of these findings warrant further investigation: repeat spirometry (some declines are measurement variability, not true physiological change), detailed respiratory history and symptom assessment, consideration of smoking status and other confounding factors, and possible referral to a respiratory physician for further investigation and diagnosis.

Importantly, a “normal” spirometry result does not exclude occupational disease. Some workers with occupational respiratory disease have preserved lung volumes but reduced airflow (restrictive pattern), others have early disease not yet detectable by spirometry. Serial assessments are more informative than individual results.

Neurological Examination Findings: Referral Criteria

Neurological examination findings requiring further investigation include: (1) gait disturbance (unsteady gait, shortened stride, postural instability), (2) tremor (resting tremor or intention tremor more prominent than expected for age), (3) rigidity (increased muscle tone with passive range of motion), (4) cognitive changes (reduced memory, impaired concentration, slowed processing), (5) mood changes (depression, aggression, anxiety) not explained by other causes, or (6) personality changes reported by worker or family. Any of these findings should trigger referral to a neurologist, preferably one experienced in occupational neurotoxicology, for further assessment and possible neuroimaging (MRI brain) to evaluate for manganese accumulation.

Chest X-Ray Abnormalities

Chest X-ray abnormalities in a welder require interpretation by an occupational or respiratory physician experienced in occupational lung disease. Small opacities (fine shadowing) in both lower lobes might indicate early welding-related pneumoconiosis; linear opacities (lines) might indicate fibrosis or scar tissue. Any abnormality should prompt follow-up imaging (repeat X-ray, high-resolution CT if indicated) and consideration of exposure history to determine relationship to welding.

Management of Workers with Abnormal Surveillance Findings

Communication of Results

All health surveillance results, normal or abnormal, must be communicated to the worker in clear, understandable language. The worker has a right to know their test results and to understand their implications. If results are abnormal, the communication should include: (1) what the abnormality is (e.g., “your lung function has declined by 12% since your last test”), (2) what it means in terms of health (e.g., “this could indicate developing lung disease”), (3) recommended actions (further investigation, change in work duties, medical follow-up), and (4) contact details for occupational health professional if the worker has questions.

Communication should be done by the occupational health professional in person if possible, or by phone if in-person consultation is impractical. Written reports should be provided to the worker and to the employer. The worker should be given opportunity to discuss results and ask questions.

Action for Suspected Occupational Disease

If surveillance findings suggest occupational disease (significant lung function decline, neurological changes, radiographic abnormalities), the following steps should be taken: (1) referral for specialist assessment: Respiratory physician for respiratory disease, neurologist for neurological disease; (2) exposure assessment: Review air monitoring and job history to establish relationship between exposure and findings; (3) work modification or cessation: If occupational disease is confirmed or suspected, the worker should be removed from welding exposure to prevent further disease progression. Alternative duties should be offered if available; (4) worker notification: The worker must be clearly informed of the suspected or confirmed diagnosis, the relationship to occupational exposure, and the recommendation for exposure cessation; (5) workers’ compensation notification: The worker should be informed of potential workers’ compensation entitlements and assisted in lodging a claim if indicated.

Clinical Follow-Up and Monitoring

Workers with abnormal surveillance findings may require ongoing clinical follow-up by their general practitioner or specialist. The occupational health service should liaise with the worker’s treating physician to ensure continuity of care. If a worker is removed from exposure due to occupational disease, follow-up assessment (spirometry, neurological examination) at 6–12 months can assess whether disease has stabilized or is progressive despite exposure cessation. For manganism, cessation of manganese exposure stops further disease progression but does not reverse existing neurological damage; neurological impairment may remain lifelong.

{{IMAGE_BODY_3}}

Health Surveillance Records and Data Management

Confidentiality and Access

Health surveillance records contain sensitive personal medical information. Records must be held securely and access restricted to: (1) the worker themselves (who has a right to their medical information), (2) the occupational health professional providing care, (3) the employer’s health and safety manager (only information needed to manage exposure and work placement, not all medical details), and (4) regulatory authorities if investigating a health and safety incident. Personal medical details should be separated from occupational hygiene or work-related information; the employer should receive work-related recommendations (e.g., “worker should be removed from stainless steel welding”) but not detailed medical diagnoses that are not necessary for work decisions.

Record Retention

Health surveillance records should be retained for the duration of the worker’s employment plus a minimum of 30 years (to account for long latency periods of occupational diseases). Records should be retained in a secure, organized manner allowing retrieval for follow-up surveillance or for potential workers’ compensation or legal claims. Digital records should be encrypted and password-protected; paper records should be locked in a secure cabinet.

Frequently Asked Questions: Health Surveillance for Welders

Is health surveillance mandatory for all welders, or only those with high exposure?

Health surveillance should be implemented for welders with exposure to welding fumes, which includes essentially all welding except minimal-fume processes in exceptionally well-ventilated conditions where air monitoring demonstrates very low exposure. As a practical matter, assume health surveillance is required for all welders unless air monitoring proves otherwise. Given the legal obligations under the WHS Act and the progressive nature of occupational disease (which may not manifest for 10–20 years), health surveillance is prudent practice for all welding operations.

Can I use the same occupational health provider for pre-placement (health monitoring) and ongoing surveillance?

Yes, and ideally you should. Continuity of care allows the occupational health provider to track health trends over time and recognize subtle changes. However, the provider must be experienced in occupational health, occupational hygiene, and the specific hazards of welding. Generic occupational health services unfamiliar with manganism, welding fume effects, or occupational neurotoxicology may provide inadequate assessment. Verify that the provider has experience with welders and understands the specific hazards of your operations.

What if an occupational health assessment shows no abnormalities but the worker reports symptoms?

Worker-reported symptoms should be taken seriously. If a welder reports respiratory symptoms, tremor, or other health changes but occupational health assessment is normal, possible explanations include: (1) early-stage disease not yet detectable by standard testing (disease progresses gradually), (2) intermittent symptoms not present during the assessment, (3) medical causes unrelated to welding (the assessment provider should have investigated alternative diagnoses), or (4) inadequacy of the assessment (some providers do not perform detailed neurological or occupational history). If symptoms persist, arrange referral to a specialist (respiratory physician, neurologist) for more detailed evaluation. Do not dismiss worker symptoms because a single occupational health assessment is normal.

Is mandatory health surveillance an invasion of worker privacy?

Health surveillance is an intrusion into personal medical information, and privacy concerns are legitimate. However, the health surveillance is justified by legitimate workplace safety reasons (detecting occupational disease early, protecting worker health), is conducted with the worker’s consent, and results are kept confidential. Workers have a right to refuse health surveillance, but refusal may preclude assignment to certain hazardous roles or may require additional controls (e.g., mandatory RPE, enhanced exposure monitoring) to manage the uncertainty about health status. Transparent communication about the purpose of health surveillance and assurance of confidentiality can address privacy concerns while maintaining the health protection intent.

What happens if a welder refuses health surveillance?

Legally, you cannot force a worker to undergo health surveillance; it requires informed consent. However, refusal should trigger a conversation: explain the health risks, the purpose of surveillance (protection, not punishment), and the confidentiality measures. Offer alternative arrangements if applicable. If a worker persistently refuses health surveillance and remains in high-exposure welding roles, the employer faces increased risk: if the worker later develops occupational disease and pursues workers’ compensation or legal action, the lack of health surveillance may weaken the employer’s defense. Documented refusal (with explanation and offered alternatives) is important for liability protection.

Conclusion: Health Surveillance as an Integral Component of Welding Safety

Health surveillance for welders is not optional compliance activity but a critical occupational health intervention that can prevent or delay serious disease, detect early-stage disease enabling intervention, and provide evidence of employer due diligence. The combination of baseline assessment, periodic surveillance, integration with air monitoring and exposure control, and systematic management of abnormal findings represents best practice in occupational health protection for welders.

Australian PCBUs and safety managers should implement health surveillance programs tailored to their operations’ exposure levels, integrate surveillance with air monitoring and engineering controls, engage experienced occupational health providers, and take abnormal findings seriously. The investment in health surveillance is modest compared to the cost of occupational disease claims, regulatory penalties, and moral imperative to protect worker health from preventable occupational disease.

Request a Health Surveillance Program Development and Implementation Quote